| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.61 (Beat by $0.04) |
| EPS GAAP Actual | $0.61 (Beat by $0.04) |
| Revenue Actual | $6.352B |
| Revenue Surprise | Beat by $6352M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 2.8845 | 8.57 | 2.83946 | 2.93406 | 4 |
| Dec 2029 | 2.97739 | 8.31 | 2.88556 | 3.16964 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -6.58 | -6.58 | 6.352B | -1.95% | 6352M |
| FQ1 2025 (Mar 2025) | 0.6 | 0.6 | 5.999B | -6.87% | 5999M |
| FQ4 2024 (Dec 2024) | 1.77 | 1.77 | 6.576B | -4.32% | 6576M |
| FQ3 2024 (Sep 2024) | -0.24 | -0.24 | 6.383B | -5.3% | 6383M |
| FQ2 2024 (Jun 2024) | 0.0839 | 0.0839 | 6.476B | 100% | 6476M |
| FQ1 2024 (Mar 2024) | 0.66 | 0.66 | 6.411B | 100% | 6411M |
| FQ4 2023 (Dec 2023) | 0.61 | 0.61 | 6.86B | 100% | 6860M |
| FQ3 2023 (Jul 2023) | 0.81 | 0.81 | 6.721B | 100% | 6721M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.67347 | -- | 0.66283 | 0.68494 | 3 |
| FQ3 2027 (Sep 2027) | 0.70397 | -- | 0.68746 | 0.72136 | 6 |
| FQ2 2027 (Jun 2027) | 0.74846 | 102.67 | 0.73091 | 0.76695 | 6 |
| FQ1 2027 (Mar 2027) | 0.65687 | 4.09 | 0.64146 | 0.6731 | 6 |
| FQ4 2026 (Dec 2026) | 0.64711 | -- | 0.63688 | 0.65814 | 3 |
| FQ3 2026 (Sep 2026) | 0.82439 | 27.22 | 0.81359 | 0.83362 | 6 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.49B | -- | 6.41B | 6.58B | 4 |
| FQ3 2027 (Sep 2027) | 6.29B | -- | 6.17B | 6.41B | 7 |
| FQ2 2027 (Jun 2027) | 6.33B | -4.52 | 6.21B | 6.45B | 4 |
| FQ1 2027 (Mar 2027) | 6.11B | 1.08 | 6B | 6.23B | 7 |
| FQ4 2026 (Dec 2026) | 6.43B | -- | 6.35B | 6.51B | 3 |
| FQ3 2026 (Sep 2026) | 6.88B | 8.15 | 6.82B | 6.94B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | -6.58 | -6.58 | 100% | |
| FQ1 2025 (Mar 2025) | 0.6 | 0.6 | 100% | |
| FQ4 2024 (Dec 2024) | 1.77 | 1.77 | 100% | |
| FQ3 2024 (Sep 2024) | -0.24 | -0.24 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0839 | 0.0839 | 100% | |
| FQ1 2024 (Mar 2024) | 0.66 | 0.66 | 100% | |
| FQ4 2023 (Dec 2023) | 0.61 | 0.61 | 100% | |
| FQ3 2023 (Jul 2023) | 0.81 | 0.81 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $6.35B | $6352M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $6B | $5999M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $6.58B | $6576M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $6.38B | $6383M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $6.48B | $6476M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $6.41B | $6411M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $6.86B | $6860M | 100% |
| FQ3 2023 (Jul 2023) | $0B | $6.72B | $6721M | 100% |